CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-06-02 | Berg Jeffrey Alan Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2010-06-02 | Bateman Terry Allan Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2010-05-27 | BUSH MICHAEL J CEO | Purchase | +200 | $0.55 | $110 | 88,078 |
| 2010-05-25 | BUSH MICHAEL J CEO | Purchase | +1,200 | $0.56 | $672 | 77,878 |
| 2010-05-25 | BUSH MICHAEL J CEO | Purchase | +10,000 | $0.57 | $6K | 87,878 |
| 2010-05-20 | BUSH MICHAEL J CEO | Purchase | +7,700 | $0.50 | $4K | 64,378 |
| 2010-05-20 | BUSH MICHAEL J CEO | Purchase | +2,300 | $0.50 | $1K | 66,678 |
| 2010-05-20 | BUSH MICHAEL J CEO | Purchase | +10,000 | $0.45 | $5K | 76,678 |
| 2010-05-19 | BUSH MICHAEL J CEO | Purchase | +1,700 | $0.48 | $816 | 56,678 |
| 2010-05-18 | BUSH MICHAEL J CEO | Purchase | +10,000 | $0.58 | $6K | 44,978 |
| 2010-05-18 | BUSH MICHAEL J CEO | Purchase | +10,000 | $0.57 | $6K | 54,978 |
| 2010-05-10 | Glassman Nicholas A EVP OF PROGRAMMING/TECHNOLOGY | Grant or award · Stock Option (Right to Buy) | +175,000 | 350,000 | ||
| 2010-04-12 | BUSH MICHAEL J CEO | Grant or award · Stock Option (Right to Buy) | +1,750,000 | 1,780,000 | ||
| 2010-03-19 | Bateman Terry Allan CEO | Option exercise | +328,125 | $0.17 | $56K | 503,958 |
| 2010-03-19 | Bateman Terry Allan CEO | Option exercise · Employee Stock Option (Right to Buy) | +328,125 | 1,276,042 | ||
| 2009-11-23 | BUSH MICHAEL J Director | Purchase | +2,000 | $0.54 | $1K | 33,000 |
| 2009-11-23 | BUSH MICHAEL J Director | Purchase | +1,400 | $0.54 | $756 | 34,400 |
| 2009-11-23 | BUSH MICHAEL J Director | Purchase | +575 | $0.54 | $311 | 34,975 |
| 2009-11-18 | BUSH MICHAEL J Director | Purchase | +5,000 | $0.50 | $3K | 25,000 |
| 2009-11-18 | BUSH MICHAEL J Director | Purchase | +6,000 | $0.48 | $3K | 31,000 |
Page 27 of 33 · 657 trades